Home » Reports » Oxford BioMedica plc 36.4% Potential Upside Indicated by Liberum Capital

Oxford BioMedica plc 36.4% Potential Upside Indicated by Liberum Capital

Oxford BioMedica plc with EPIC/TICKER (LON:OXB) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Liberum Capital. Oxford BioMedica plc are listed in the Health Care sector within UK Main Market. Liberum Capital have set their target price at 1050 GBX on its stock. This now indicates the analyst believes there is a possible upside of 36.4% from the opening price of 769.94 GBX. Over the last 30 and 90 trading days the company share price has increased 41.94 points and increased 229.94 points respectively. The 1 year high for the share price is 860 GBX while the year low stock price is currently 356.73 GBX.

Oxford BioMedica plc has a 50 day moving average of 777.10 GBX and the 200 Day Moving Average price is recorded at 647.86. There are currently 82,002,369 shares in issue with the average daily volume traded being 243,276. Market capitalisation for LON:OXB is £637,158,407 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn